International Keynote Speakers
Saeed Hamid - Dr. SAEED SADIQ HAMID, MBBS, FRCP, FRCPI, FACP, FACG, FAASLD. Director, Clinical Trials Unit, Professor & Consultant Gastroenterologist, Department of Medicine.
Sharon Hutchinson -Sharon Hutchinson is a Professor of Epidemiology and Population Health at Glasgow Caledonian University and holds an honorary appointment at Health Protection Scotland. She has over 20 years experience in conducting epidemiological research to inform on the design and impact of public health interventions. Authoring over 180 publications and PI/co-I on grants worth over £15 million, she leads a broad translational research programme on the prevention, diagnosis, and treatment of hepatitis C (HCV) and other blood-borne viruses. Her research provided the key evidence to guide a public health response to HCV in Scotland, which culminated in Scottish Government investing significantly in their Action Plan (£100 million during 2008-15). The evidenced-based National Plan was the stimulus for WHO and the World Hepatitis Alliance staging their inaugural World Hepatitis Summit (involving governments and civil society representatives from over 80 countries) in Glasgow during 2015.
Giten Khwairakpam - Giten is currently the Community and Policy Program Manager at amfAR’s TREAT Asia program in Bangkok, Thailand. He is a member of World Health Organization’s Global Guidelines Development Group on hepatitis B and hepatitis C and a member of the Expert Advisory group on HCV with the Medicines Patent Pool. He also has served in different technical groups on viral hepatitis in WHO WPRO and SEARO region. He has been working on improving hepatitis C treatment access and advocating for price reductions in South and South East Asia in partnership with regional and national community networks. He was also profiled as a Change Maker for hepatitis C by the Economist Intelligence Unit in 2016.
Dee Lee - Director and founder of Inno Community Development Organisation, an Nonprofit that aims at creating social impact through social innovation pursuing a dream of a healthy and just society. Inno created the largest and one of most influential Fight Hepatitis Discrimination Programme in Asia which helped 238 factories to remove the job screening of people with hepatitis. In 2009 Inno worked together with hundreds of millions of people to start the hepatitis self-support network in China. Inno is awarded by domestic and international entities in social innovation and philanthropy area.
Su Wang, MD, MPH is the Medical Director of the Center for Asian Health, a comprehensive medical practice serving the Asian community in New Jersey. Dr. Wang practices internal medicine and leads the Center’s growth, outreach and grant programs as part of Saint Barnabas Medical Center (SBMC) and the RWJBH network. Previously, she directed the Hepatitis B Program at Charles B. Wang Community Health Center in New York City, where she led its nationally recognized programs in primary care-based hepatitis B care and community based participatory research.
Chris Cunningham, of the Ngati Toa and Ngati Raukawa tribes of New Zealand (NZ), is Professor of Maori Health and has been Director of the Research Centre for Maori Health & Development at Massey University’s Wellington Campus since 1996. He has a strong background in both policy development and research.
He is current Chair of the Hepatitis Foundation of New Zealand and has been co-Chair of the World Indigenous Peoples’ Conferences on Viral Hepatitis, held in Alice Springs in 2014 and Anchorage, Alaska in 2017.
Chris is Director of two major Maori research programmes and is currently supervising 5 doctoral students, having supervised 28 PhDs and 14 post-docs to completion.
His major research interests include non-communicable diseases (especially hepatitis B/C, cancer, diabetes and insulin resistance), whanau (family) health & development, ageing, longitudinal research, school-based interventions in physical activity and nutrition, and housing & health.
Margaret Hellard, AM was appointed Deputy Director of the Burnet Institute in March 2017, prior to this appointment she was Head, Centre for Population Health from 2002-2017. She is Head of Hepatitis Services in the Infectious Diseases Unit at The Alfred Hospital.
Stuart Loveday is the CEO of Hepatitis NSW, Australia's first community based organisation and health promotion charity working for and on behalf of people with viral hepatitis. He is a former President and was a founding Board of Hepatitis Australia. Having worked in the hepatitis sector for almost 25 years, Stuart will be stepping down from his role in October 2019.
Jacqui Richmond has worked in the viral hepatitis sector in a variety of roles in nursing, education, research and policy development. She currently works at the Burnet Institute as the Workforce Development and Health Service Delivery Project Manager for the EC Australia partnership.
Alex Thompson, Director, Department of Gastroenterology, St Vincent’s Hospital, Melbourne. Alex Thompson is Professor-Director of Gastroenterology at St. Vincent’s Hospital Melbourne (University of Melbourne) Director of State-wide Hepatitis Program in Victorian prisons.